TY - JOUR
T1 - Molecular Design of Phthalocyanine-Based Drug Coassembly with Tailored Function
AU - Li, Dong
AU - Huang, Siyong
AU - Ge, Jianlin
AU - Zhuang, Ziqi
AU - Zheng, Longyi
AU - Jiang, Lai
AU - Chen, Yulun
AU - Chu, Chengchao
AU - Zhang, Yang
AU - Pan, Jie
AU - Cheng, Bingwei
AU - Huang, Jian Dong
AU - Lin, Huirong
AU - Han, Wei
AU - Liu, Gang
N1 - This work was supported by the Major State Basic Research Development Program of China (2023YFB3810000), the National Natural Science Foundation of China (NSFC) (81925019, 82202330, U22A20333, 21977011, and 82302271), the Program for New Century Excellent Talents in University, China (NCET-13-0502), the Shenzhen Fundamental Research Program( Grant No . GXWD20201231165807007, 2020082717013200, and B2302014), the China National Postdoctoral Program for Inovative Talents (BX20220188), the Jimei University Research Initiation Fund Project (ZQ2024079), and the Education and Research Foundation for Young Teachers of Education department of Fujian Province (JAT231045 and 2022J011403).
Publisher Copyright:
© 2024 American Chemical Society.
PY - 2024/12/11
Y1 - 2024/12/11
N2 - Coassemblies with tailored functions, such as drug loading, tissue targeting and releasing, therapeutic and/or imaging purposes, and so on, have been widely studied and applied in biomedicine. De novo design of these coassemblies hinges on an integrated approach involving synergy between various design strategies, ranging from structure screening of combinations of “phthalocyanine-chemotherapeutic drug” molecules for molecular scaffolds, exploration of related fabrication principles to verification of intended activity of specific designs. Here, we propose an integrated approach combining computation and experiments to design from scratch coassembled nanoparticles. This nanocoassembly, termed NanoPC here, consists of phthalocyanine-based scaffolds hosting chemotherapeutic drugs, aimed at hypersensitive chemotherapy guided by photoimaging for targeting tumors. Our design starts from the selection of phthalocyanine derivatives that are not aggregation-prone, followed by computational screening of coassembled molecules covering various categories of chemotherapy drugs. To facilitate an efficient and accurate assessment of coassembly capabilities, we utilize small systems as surrogates to enable free-energy calculations at all-atom levels facilitated with enhanced sampling and statistical mechanics for efficient and accurate evaluation of coassembly ability. The final top NanoPC candidate, comprised of phthalocyanine PcL and cytarabine (CYT), can greatly increase the fluorescence intensity ratio of tumor/liver by 21.5 times and achieve higher antitumor efficiency in a pH-dependent manner. Therefore, the designing approach proposed here has a potential pattern, which can provide ideas and references for the design and development of coassembled nanodrugs with tailored functions and applications in biomedicine.
AB - Coassemblies with tailored functions, such as drug loading, tissue targeting and releasing, therapeutic and/or imaging purposes, and so on, have been widely studied and applied in biomedicine. De novo design of these coassemblies hinges on an integrated approach involving synergy between various design strategies, ranging from structure screening of combinations of “phthalocyanine-chemotherapeutic drug” molecules for molecular scaffolds, exploration of related fabrication principles to verification of intended activity of specific designs. Here, we propose an integrated approach combining computation and experiments to design from scratch coassembled nanoparticles. This nanocoassembly, termed NanoPC here, consists of phthalocyanine-based scaffolds hosting chemotherapeutic drugs, aimed at hypersensitive chemotherapy guided by photoimaging for targeting tumors. Our design starts from the selection of phthalocyanine derivatives that are not aggregation-prone, followed by computational screening of coassembled molecules covering various categories of chemotherapy drugs. To facilitate an efficient and accurate assessment of coassembly capabilities, we utilize small systems as surrogates to enable free-energy calculations at all-atom levels facilitated with enhanced sampling and statistical mechanics for efficient and accurate evaluation of coassembly ability. The final top NanoPC candidate, comprised of phthalocyanine PcL and cytarabine (CYT), can greatly increase the fluorescence intensity ratio of tumor/liver by 21.5 times and achieve higher antitumor efficiency in a pH-dependent manner. Therefore, the designing approach proposed here has a potential pattern, which can provide ideas and references for the design and development of coassembled nanodrugs with tailored functions and applications in biomedicine.
UR - http://www.scopus.com/inward/record.url?scp=85210119001&partnerID=8YFLogxK
UR - https://pubs.acs.org/doi/10.1021/jacs.4c10070
U2 - 10.1021/jacs.4c10070
DO - 10.1021/jacs.4c10070
M3 - Journal article
AN - SCOPUS:85210119001
SN - 0002-7863
VL - 146
SP - 33461
EP - 33474
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 149
ER -